Fact CheckerSign in

NCT06574178Recruiting

Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet

Source: ClinicalTrials.gov · Last updated 16 Jun 2026

Brief summary (registry, in English)

Psoriasis is a chronic inflammatory disease that affects the skin and joints in 2-3 % of people in the United States. This inflammation of the skin, joints, and blood vessels in patients with psoriasis has been measured by older PET Scan technology but with limitations. With the new EXPLORER PET scanner technology, the investigators are testing to see if the EXPLORER is better than previous PET scanners and improve our ability to assess inflammation in patients. Also, it is known that the typical Western Diet - high in saturated fats, added sugars, and low in fiber - contributes to obesity and inflammation worldwide. There is evidence in animals that these signs of inflammation are reversible within 4 weeks when changed to a more balanced diet. Thus, this study aims to assess whether there are detectable decreases in inflammation of the skin and body of psoriasis patients who usually eat a Western Diet on an EXPLORER PET scan following 6 weeks of a more balanced diet.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
5 (estimated)
First submitted
15 Aug 2024
Start date
1 Jan 2025
Primary completion date
1 Sept 2026
Lead sponsor
University of California, Davis
Diseases
Psoriasis
NCT number
NCT06574178

What you commit to

  • Study type: Interventional
  • Planned participants: 5
  • From 1 Jan 2025 to the primary completion date, 1 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Those taking anti-diabetic oral or injected medications
  • Those taking systemic medications for the purpose of treating psoriasis or psoriatic arthritis for at least 3 months prior to first PET scan or during the duration of the trial
  • Pregnant or breast-feeding (urine pregnancy test will be administered prior to start of each PET/CT session for all participants who are able to get pregnant between 18 to 60 years old, unless documented hysterectomy or bilateral ovarian removal is available, because of risks from ionizing radiation)
  • Currently participating in another conflicting research study. Concurrent or prior enrollment in a separate research study involving a PET scan performed within the last 12 months for research purposes only.

Other illness

  • Vegan, vegetarian or food allergy or intolerance to the ingredients of the diet
  • Self-reported history of dysphoria or anxiety in closed spaces (claustrophobia)
  • Known inflammatory or other infectious disease that can confound assessment

Lab values

  • Uncontrolled diabetes or blood glucose level greater than 180 mg/dl at the time of radiotracer injection

Other

  • Those already ingesting a caloric- or component-restricted diet
  • \>5% change in body weight in the last 2 months
  • Body weight \>240 kg due to limitations of the scanner bed
  • Inability to lie motionless on the scanner bed with the arms by the side for up to 60 minutes
  • Unwilling to sign informed consent
  • Inability to understand the risks and benefits of the study
  • Prisoners

Who the study is looking for

  • Adults (\>18 year)
  • Both sexes
  • Must have a history of psoriasis of at least 3% body surface area affected by skin psoriasis (in a body area that the subject will allow the PI to perform several skin biopsies as noted below (optional)) and may carry a diagnosis of psoriatic arthritis as well
  • Patients will have a BMI of \>/=25 which is consistent with being overweight - Willing and able to fast for at least 6 hours before and for the duration of the scan visit
  • No strenuous exercise for 24 hours prior to being scanned
  • Recruited patients must habitually consume a WD-type diet that will be evaluated by using DHQ III food frequency questionnaire along with three-day food record14. Subsequently, the Healthy Eating Index will be calculated and participants with a poor dietary pattern (score below 58) will be eligible for the study15.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of California, Davis - Dermatology Department
Coordinator of this site? Confirm its status
SacramentoUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.